Skip to main content
Christopher Klebanoff, MD, Oncology, New York, NY

Christopher Austin Klebanoff MD


Physician

Request Appointment
  • 530 East 74th StreetNew York, NY 10021

  • Book by Phone+1(231) 515-5263

Overview of  Dr. Klebanoff

Dr. Christopher Klebanoff is an oncologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. He received his medical degree from Emory University School of Medicine and has been in practice 11 years. He is one of 506 doctors at Memorial Sloan Kettering Cancer Center who specialize in Oncology. He has more than 70 publications and over 500 citings.

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 2008 - 2011
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 2006 - 2008
  • Emory University School of Medicine
    Emory University School of MedicineClass of 2006

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2016 - 2026
  • MD State Medical License
    MD State Medical License 2008 - 2016
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Press Mentions

  • A New Cellular Immunotherapy Approach May Offer Treatment for AML and MDS
    A New Cellular Immunotherapy Approach May Offer Treatment for AML and MDSApril 23rd, 2025
  • MSK Research Highlights, March 3, 2025
    MSK Research Highlights, March 3, 2025March 3rd, 2025
  • Damon Runyon Cancer Research Foundation Awards $4.8 Million to Exceptional Early-Career Scientists
    Damon Runyon Cancer Research Foundation Awards $4.8 Million to Exceptional Early-Career ScientistsAugust 28th, 2024
  • Join now to see all

Grant Support

  • Novel cell therapy approaches for molecularly defined subsets of therapy-resistant melanomaSLOAN-KETTERING INST CAN RESEARCH2023–2028
  • Molecular mechanisms of T cell responses to a clonal neoantigen resulting from a mutated driver oncogene.SLOAN-KETTERING INST CAN RESEARCH2021–2026

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: